1 Vascular Biology Unit, The heat shock protein heme oxygenase-1 (HO-1)
is regulated by a variety of physiological and pharmacological factors.
In skeletal muscle tissue, HO-1 has been shown to be induced only by
exercise and electrical stimulation in vivo. Both hemin and sodium
nitroprusside (SNP) are potent inducers of HO-1 in other tissues. In
this study, we examined the effects of these two agents on HO-1
induction in L6.G8 rat skeletal myoblast cells. Hemin and SNP increased
cellular heme oxygenase activity in both a time- and
concentration-dependent manner. Increases in the HO-1 mRNA level and
protein expression accompanied changes in heme oxygenase activity. The
ability of SNP to induce HO-1 in L6.G8 cells was reduced by
coincubation with hydroxocobalamin, a known nitric oxide (NO)
scavenger, suggesting that NO itself may be involved in HO-1 gene
stimulation. These results indicate that HO-1 expression is sensitive
to both hemin and SNP in skeletal myoblast cells and may indicate an
important regulatory mechanism of heme catabolism in skeletal muscle
tissue.
heme; heme proteins; hydroxocobalamin; heat shock protein 32; myoglobin
THE GENERATION OF FREE radical species during oxidative
stress has been implicated in the pathogenesis of cellular damage (11).
Free heme is a major source of iron that contributes to the generation
of hydroxyl radicals by the Fenton reaction (7). Heme itself is
released from intracellular heme proteins during increased free radical
production (24). Although the precise source of this free heme is
uncertain, the following sources have been suggested: denaturation of
intracellular heme proteins by free radicals, newly synthesized heme
not utilized for de novo heme protein assembly because redox changes in
the cell prevent constitutive protein formation, and circulating
hemoglobin that has entered the cell following membrane damage (14). In
addition to these, certain cell types have very high levels of an
alternative source of intracellular heme, namely, erythrocytes, in the
form of hemoglobin, and myocytes, in the form of myoglobin. The
regulation of heme turnover in these cells is therefore of particular
interest.
Heme oxygenase is a microsomal enzyme, widely distributed in mammalian
tissues, which has a major role in heme metabolism. It catalyzes the
oxidation of heme to biliverdin and carbon monoxide (13). Two isoforms
have been identified that are separate gene products: heme oxygenase-1
(HO-1), the inducible form (also known as heat shock protein 32), and
HO-2, the constitutive form (16). Recently, evidence of a second
constitutive isoform (HO-3) has been found (12). The role of heme
oxygenase in different tissues has not, as yet, been fully
characterized, but it is becoming evident that it is involved in a
variety of cellular regulatory and protective mechanisms. HO-1 has been
shown to be protective against ischemia-reperfusion and free
radical damage in a number of tissues (15, 22, 36). Several possible
mechanisms for this protection have been proposed:
1) elimination of the pro-oxidant free heme could decrease hydroxyl radical formation, thereby reducing cellular damage; 2) biliverdin and
the reduced product bilirubin are both potent free radical scavengers
with antioxidant properties (32); and
3) carbon monoxide, as a vasodilator
(6), could play an important role in maintaining cellular integrity and
function under certain conditions such as ischemia (14). The
relative importance of each of these factors in cytoprotection under
different pathophysiological conditions has not been established but is currently under investigation.
Myoglobin, a potential source of free heme, is released from skeletal
muscle during severe ischemia-reperfusion injury and is
implicated in the pathogenesis of acute renal failure. The precise
mechanism of this is unclear; however, both iron released from heme
(23) and
H2O2
generation mediated by heme (27) have been proposed as mediators of the
damage. Induction of HO-1 in the kidney has been shown to protect
against this form of renal injury (20). Whether a similar mechanism of
injury occurs in the muscle itself during ischemia-reperfusion
and whether HO-1 has a protective role in this tissue are not known.
The HO-1 isoform is extremely sensitive to a variety of agents that
cause oxidative stress, including heat shock (29), ischemia (15), hypoxia (19), and endotoxin (36). It is also inducible by hemin
(31, 33, 37) and the free radical nitric oxide (NO) (3, 5, 17). HO-1 is
induced in rat skeletal muscle following exhaustive exercise and
electrical stimulation (4); however, no other inducer of HO-1 in
skeletal muscle has been identified. We set out to investigate the
effect of two known inducers [hemin and sodium nitroprusside
(SNP), an NO donor] on the expression of HO-1 in skeletal
myoblast cells to establish whether its regulation is similar to that
of other cell types.
Materials.
Hemin was obtained from Porphyrin Products (Logan, UT). Rabbit
polyclonal antibody to HO-1 was obtained from StressGen (Victoria, BC,
Canada). All other reagents were obtained from Sigma-Aldrich (Poole,
UK).
Cell culture and incubations.
L6.G8 rat skeletal muscle myoblasts were obtained from the European
Collection of Animal Cell Cultures (Salisbury, UK). Cells were seeded
at a density of 106 cells/ml in
75-cm2 culture flasks and grown to
confluence in complete medium (DMEM supplemented with 10%
heat-inactivated fetal bovine serum, 2 mM L-glutamine, 100 U/ml
penicillin, and 100 µg/ml streptomycin). Flasks were kept at 37°C
in a humidified atmosphere of air and 5%
CO2. To determine the effect of
hemin and SNP on the expression and activity of heme oxygenase in
myoblast cells, the complete medium was replaced with incubation
medium. This was made by preparing stock solutions of hemin, SNP,
hydroxocobalamin (HCB), or cadmium chloride, which were then sterilized
through a 0.22-µm filter and diluted to the desired concentration in
complete medium. Serum-rich medium was used throughout to minimize
variables and prevent HO-1 induction by stress caused by alteration of
the serum content of the incubation medium (35).
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
Measurement of heme oxygenase activity.
Cells were manually scraped from
75-cm2 flasks and collected in 10 ml of cold 10× PBS. Cells were centrifuged at 8,000 g at 4°C for 10 min. The pellet
was resuspended in 500 µl phosphate buffer (100 mM
KH2PO4 + 2 mM MgCl2, pH 7.4). The cell
suspension was freeze-thawed (80 to 37°C) three times and
sonicated for 15 s in ice water. Heme oxygenase activity was then
assayed as previously described (18).
Measurement of HO-1 mRNA by Northern blot analysis.
Cells were washed with cold PBS and then lysed directly in flasks by
addition of guanidinium thiocyanate buffer, and total RNA was extracted
using the method of Chomczynski and Sacchi (2). Total RNA (10 µg/lane) was run on a 1.3% denaturing agarose gel containing 2.2 M
formaldehyde and transferred onto a nylon membrane, according to the
method of Tyrrell and Basu Modak (35). The membrane was hybridized
using
[-32P]dCTP-labeled
cDNA probes to the rat HO-1 gene (the 88- to 971-nucleotide residue
fragment of the rat heme oxygenase gene) (30) and the rat
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene. The hybridized
membranes were exposed to radiographic film.
Measurement of HO-1 mRNA by RT-PCR.
RT-PCR was used to verify the Northern blot analysis results. Total RNA
(1 µg) was reverse transcribed using random hexamer primers (GeneAmp
RNA PCR kit, Perkin-Elmer, Norwalk, CT). With the use of a manual hot
start, the cDNA was amplified using 2.5 units of AmpliTaq
DNA polymerase (Perkin-Elmer), with the 3' and 5' primers
for both -actin and HO-1 being added to the same reaction tube
(these yielded products of 247 and 583 bp, respectively). After an
initial melting at 95°C, the PCR mixtures were amplified using a
UNO II thermocycler (Biometra, Göttingen, Germany) for a total of
34 cycles, using a two-step protocol of melting at 95°C for 1 min
and annealing at 61°C for 1.5 min. The product (20 µl/lane) was
run on a 2.5% agarose gel (Metaphor agarose, FMC Bioproducts,
Rockland, ME).
Measurement of HO-1 protein. HO-1 protein was measured using Western blot analysis. Cells were manually scraped from 75-cm2 flasks and collected in 10 ml of cold PBS. Cells were centrifuged at 8,000 g at 4°C for 10 min. The pellet was resuspended in 500 µl PBS containing 1% Triton X-100. The total amount of protein was measured using a commercial protein assay kit (Bio-Rad Laboratories, Hemel Hempstead, UK), and 30 µg of total protein were boiled in Laemmli buffer (10). Samples were separated on a 15% SDS-polyacrylamide resolving gel. Proteins were electrophoretically transferred onto a nitrocellulose membrane, and nonspecific antibody binding was blocked with 3% nonfat dried milk. The membrane was then probed with anti-HO-1 antibody (1:1,000 dilution) for 2 h at room temperature. Blots were visualized using an alkaline phosphatase staining kit (Rabbit ExtrAvidin, Sigma-Aldrich, Poole, UK).
Measurement of cell viability. L6.G8 cells were seeded in 96-well plates at a density of 106 cells/ml and grown to confluence in complete medium. Incubations were performed as described in Cell culture and incubation above. At the end of the experimental incubation period, the medium was replaced with tetrazolium reagent (CellTiter 96 AQueous One Solution Cell Proliferation Assay, Promega, Southampton, UK), diluted in complete medium according to the manufacturer's protocol. Cells were then further incubated for 60 min at 37°C. The generation of the formazan product was assessed optically by measuring the absorbance at 490 nm using a plate reader and analytical software (Spectra Max250 and SOFTmax PRO, respectively, Molecular Devices, Crawley, UK). Results were expressed as a percentage of the control group.
Statistical analysis. One-way ANOVAs followed by Bonferroni t-tests were used for the statistical analyses of data. All values were expressed as means ± SE, and differences between groups were considered significant at P < 0.05.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Effect of hemin and SNP concentration on heme oxygenase activity. To examine whether hemin and SNP increased heme oxygenase activity, L6.G8 cells were treated for 6 h with incubation medium containing either hemin or SNP. Figure 1A illustrates the change in heme oxygenase activity after incubation with a range of concentrations of hemin. Heme oxygenase activity was significantly elevated when cells were treated with 50 µM hemin (P < 0.01) and continued to increase in a concentration-dependent manner with a peak at 200 µM. At this concentration there was a 7.8-fold increase in heme oxygenase activity compared with the control value. At higher concentrations of hemin (300-400 µM), a slight but significant decrease from the maximum in heme oxygenase activity was observed (P < 0.05). A concentration-dependent response was also seen after incubation of cells with SNP (Fig. 1B). Heme oxygenase activity significantly increased at a concentration of 0.1 mM SNP (P < 0.01), rising to a peak at 0.5 mM. At this concentration, there was a 5.0-fold increase in activity compared with the control value. Similarly to hemin treatment, exposure of cells to higher concentrations of SNP (1-2 mM) resulted in a significant decrease in activity from the maximum (P < 0.05).
|
Effect of duration of incubation with hemin or SNP on heme oxygenase activity. To examine the rate of change of heme oxygenase activity in response to hemin and SNP, L6.G8 cells were treated with incubation medium for different durations (0-24 h). With the use of the optimal concentration of hemin (200 µM) and SNP (0.5 mM) for maximal heme oxygenase activation, heme oxygenase activity increased in a time-dependent manner compared with control (Fig. 2, A and B). Within 3 h, heme oxygenase activity was significantly increased in response to both hemin and SNP stimulation (P < 0.01). Heme oxygenase activity continued to increase in a time-dependent manner with a peak at 6 h for both treatments. In both groups, heme oxygenase activity showed a decrease from maximum after a 24-h incubation, although it remained significantly greater than control (P < 0.05 with SNP and P < 0.01 with hemin).
|
Induction of HO-1 mRNA and protein by hemin and SNP. To establish whether changes in heme oxygenase activity following hemin and SNP treatment were associated with changes in gene expression and de novo protein synthesis, HO-1 mRNA and protein levels were determined. HO-1 mRNA expression in L6.G8 cells following incubation with hemin was analyzed by Northern blot analysis (Fig. 3A). A concentration-dependent response in HO-1 mRNA levels was seen with a marked increase, compared with control, in HO-1 transcript across the entire concentration range (50-400 µM). These results were confirmed by RT-PCR using specific primers for HO-1 (Fig. 3B). Similarly, Western blot analysis of hemin-treated cells (Fig. 3C) showed a marked concentration-dependent increase in HO-1 protein levels above control, which paralleled the changes in HO-1 mRNA levels. It is interesting to note that HO-1 mRNA and protein levels increased during incubation with 0-200 µM hemin to concur with changes in heme oxygenase activity. At higher concentrations of 300 and 400 µM hemin, however, HO-1 mRNA and protein levels increased further, whereas heme oxygenase activity decreased from maximum. After incubation of L6.G8 cells with SNP, a marked increase in HO-1 mRNA was seen. Once again, HO-1 mRNA did not appear to diminish with higher concentrations (1 and 2 mM SNP), in contrast to changes seen in heme oxygenase activity (Fig. 4).
|
|
Effect of HCB on SNP-stimulated heme oxygenase activity and HO-1 mRNA expression. To determine whether heme oxygenase activity is stimulated by the release of NO from SNP, cells were incubated with HCB, an NO scavenger. The increase in heme oxygenase activity with 0.5 mM SNP was significantly (P < 0.01) attenuated by 0.5 mM HCB to 38% of the SNP-stimulated value. HCB alone had no effect on the basal level of heme oxygenase activity (Fig. 5). These changes in heme oxygenase activity were reflected by changes in HO-1 gene expression. HO-1 mRNA expression as determined by Northern blot analysis is shown in Fig. 6A. Compared with control, a marked increase in HO-1 expression was seen in response to SNP and this was greatly attenuated by coincubation of cells with 1.0 mM HCB. To discriminate between the NO-scavenging properties and other free radical-scavenging properties of HCB, a further experiment was performed. Cells were incubated for 6 h in the presence of 10 µM cadmium chloride, with and without 1.0 mM HCB. HO-1 protein was greatly increased in cells incubated with SNP or cadmium alone. Simultaneous incubation with HCB markedly reduced both the amount of HO-1 mRNA and protein in SNP-treated cells but not in cadmium-treated cells (Fig. 6, A and B).
|
|
Effect of hemin and SNP on cell viability. Hemin and SNP, through the release of iron and cyanide and the generation of free radicals, may be harmful to cells. To establish the conditions under which hemin and SNP cause significant cellular damage, cell viability was determined using a tetrazolium assay following incubation with various concentrations of hemin and SNP. As shown in Fig. 7A, there was a gradual concentration-dependent decrease in viability, compared with control cells, which was more marked in the SNP- than the hemin-treated group. At 200 µM hemin and 0.5 mM SNP (both representing concentrations of maximal heme oxygenase activity), cell viability decreased to 89 ± 1.4% and 82 ± 2.1% of control, respectively. At the highest concentrations used (400 µM hemin and 2 mM SNP), the decrease in cell viability was most dramatic, declining to 75 ± 4.0% and 28 ± 1.0%, respectively. Cell viability also declined with duration of incubation (Fig. 7B). At 6 h, both hemin and SNP caused a significant decrease in cell viability (88 ± 1.5% and 84 ± 2.2%, respectively). An even greater reduction was seen at 24 h, resulting in cell viability of 77 ± 14% in hemin-treated cells and 45 ± 7.5% in SNP-treated cells, compared with control. The decline in heme oxygenase activity seen with both higher concentrations of inducing agent and longer durations of incubation coincided with the decrease in cell viability.
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In this study, we have demonstrated that heme oxygenase activity can be stimulated by both hemin and SNP in L6.G8 skeletal myoblast cells and that this activation is associated with a concomitant increase in both HO-1 mRNA and protein levels. Our results support the finding of Essig et al. (4) that HO-1 can be stimulated in rat skeletal muscle. The present study suggests that heme and NO may be important regulators of HO-1 and heme turnover in skeletal muscle tissue in vivo. This could be of clinical relevance in certain pathophysiological situations, such as ischemia, which are characterized by heme release (23) and the cytokine-mediated increase in NO levels (21).
We have shown that the response to hemin stimulation in L6.G8 cells is very similar to that of other cell types. A significant increase in heme oxygenase activity has been found in human macrophages and human glioma cells after a 5-h incubation with hemin (37). Similarly, an increase was seen in pig alveolar macrophages with a peak at incubations of 5-7 h and a gradual decline in stimulated levels of heme oxygenase activity at longer incubation periods (31). These findings agree with our results, showing a peak in heme oxygenase activity after a 6-h incubation with a subsequent decline from maximum at longer durations. In both of these studies, lower concentrations of hemin were used than in the present study. Shibahara et al. (31) found a peak in heme oxygenase activity at 5 µM hemin, with a decline from maximum at higher concentrations, whereas L6.G8 cells responded maximally at 200 µM hemin but similarly declined at higher concentrations. L6.G8 cells may be less sensitive to hemin compared with other cell types studied or this difference may be a reflection of the incubation conditions. Our study was performed in serum-rich medium, whereas the other two studies were performed in serum-free medium. The added serum may reduce the amount of hemin available for cell stimulation because of binding to proteins such as albumin.
Western and Northern blot analyses (confirmed by RT-PCR) were performed to establish whether changes in heme oxygenase activity were a result of transcriptional induction and de novo protein synthesis or due to posttranslational protein activation. Both HO-1 protein and mRNA levels were found to increase with increasing hemin concentration, thereby confirming that changes in heme oxygenase activity occurred at the transcriptional level. No decreases in either protein or mRNA levels were observed at higher concentrations of hemin, indicating that the decline from maximum in heme oxygenase activity was not due to downregulation of gene expression. This suggests that at very high concentrations (300-400 µM) hemin remains an inducer of HO-1 but that it also can potentially inhibit the activity of the heme oxygenase enzyme.
The response of L6.G8 cells to SNP was also similar to that of other cell types studied. Bovine aortic endothelial cells showed a significant increase in HO-1 protein expression and heme oxygenase activity after incubations of 4 and 6 h with 1 mM SNP (5, 17). Similarly, rat vascular smooth muscle cells incubated with 1 mM SNP showed a significant increase in HO-1 protein expression after 4 h, which, however, continued to increase up to 24 h (3). In the present study, we also found that HO-1 protein levels increased in a concentration-dependent manner across the range of 0.1-1.0 mM SNP. L6.G8 cells responded to SNP with maximal heme oxygenase activity at 0.5 mM. In contrast to rat vascular smooth muscle cells, a decline from maximum in heme oxygenase activity was observed at higher concentrations (3). This suggests that L6.G8 skeletal muscle cells may be more sensitive than vascular smooth muscle cells to the potential toxic effect of SNP or its metabolites.
Both hemin and SNP caused loss of cell viability at all concentrations and durations examined. The data indicate that when both hemin and SNP induce heme oxygenase activity they also cause cellular damage. This damage may be caused by the inducers directly, by their metabolites, or via free radical formation. It is interesting to observe that at maximal heme oxygenase activity (6-h incubation with 200 µM hemin or 0.5 mM SNP) cell viability was similar with both hemin and SNP treatment, decreasing to 89 and 83% of control, respectively. With longer durations and higher concentrations of inducer, heme oxygenase activity diminished from its peak value. This decrease correlated directly with a further and more dramatic loss in cell viability. Despite this decrease in cell viability, both HO-1 mRNA and protein expression did not decline with higher concentrations of hemin (300 and 400 µM). This indicates that, under conditions of extreme stress, hemin-induced HO-1 expression is better preserved than enzyme function, suggesting that loss of heme oxygenase activity may correlate with pronounced impairment of cell viability. The possibility exists that at very high concentrations of inducer the HO-1 protein becomes a target for damage by free radicals generated by SNP or heme.
SNP is metabolized to a number of products, many of which could potentially be implicated in HO-1 induction. These include NO, iron, cyanide, and oxygen free radicals (26). HCB is a known scavenger of NO and was used to assess the contribution of NO to SNP-mediated increases in heme oxygenase activity. The attenuation of SNP-stimulated heme oxygenase activity by HCB in L6.G8 cells is consistent with findings in bovine aortic endothelial cells. Foresti et al. (5) showed a significant reduction, by about two-thirds, in SNP-stimulated heme oxygenase activity by 0.5 mM HCB (compared with a reduction of 62% found in this study). The fact that HCB did not completely suppress the increase in heme oxygenase activity and HO-1 mRNA expression is probably due to either incomplete blockade of NO or participation of other metabolites of SNP in HO-1 stimulation. Cyanide does not appear to be an inducer of HO-1 in vitro (17) and therefore was unlikely to contribute to the stimulation of heme oxygenase activity by SNP in our experiments. To exclude the contribution of free radicals, either generated from iron via the Fenton reaction or released directly from SNP degradation, additional experiments were conducted by exposing cells to cadmium. Cadmium is an extremely potent inducer of HO-1 (8) and is known to generate free radicals, particularly hydroxyl radicals (28). HCB did not reduce the degree of heme oxygenase induction by cadmium. This strongly suggests that, in our experiments, HCB is not a scavenger of free radicals but is a specific scavenger of NO, released from SNP. It is therefore unlikely that the SNP-stimulated heme oxygenase activity attenuated by HCB is mediated by free radicals other than NO or its derivatives (5). From these findings, it appears that, of all the potential inducers of HO-1 released from SNP, NO has by far the greatest contribution. This adds further supporting evidence to previously published data on the significance of NO in HO-1 induction (3, 5, 17).
The precise mechanism of HO-1 induction is not known. Many inducible
genes are expressed in response to activation of various transcriptional factors by a variety of inducing agents. The binding sites of many transcriptional factors have been identified in the
promoter region of the HO-1 gene, and it appears that HO-1 expression
is regulated by the activation and binding of such transcriptional
factors to these regions (1). An increase in the binding of a number of
transcriptional factors in response to hemin treatment has been
demonstrated, most significantly activator protein-2 and
nuclear transcription factor-B (34). Heme is a known potent inducer
of HO-1, and, if it stimulates HO-1 induction via activation of
transcriptional factors, then modulation of intracellular free heme
concentration would be a sensitive mechanism for HO-1 regulation. The
mechanism of NO induction of HO-1 is less clear because no
transcriptional factor sensitive to NO has been identified. NO,
however, does appear to be able to displace heme from heme proteins
(9); therefore, it is possible that NO is capable of regulating HO-1
levels via modulation of the intracellular free heme concentration.
In summary, we have been able to demonstrate that heme oxygenase activity is significantly increased in rat skeletal myoblasts following exposure to hemin and the NO donor, SNP, and that changes in activity are paralleled by both increased HO-1 protein levels and mRNA expression. The role of heme oxygenase in skeletal muscle is still unclear. Its two functions of cellular protection against oxidative stress and regulation of heme turnover would suggest an important biological role in skeletal muscle cells under both normal and pathophysiological conditions. The inducible isoform, HO-1, has been recently identified in rat skeletal muscle tissue in vivo (4). We have been able to verify significant induction of HO-1 by ischemia-reperfusion in human skeletal muscle samples taken from free muscle flap transfers before and during vessel division and after reanastomosis (data not shown). It has been demonstrated that HO-1 is protective against heme-mediated damage in the kidney during rhabdomyolysis following muscle ischemia (20). On the basis of the evidence in skeletal myoblast cells presented here, the possibility exists that HO-1 may have a similar function in heme-rich tissues, such as muscle. Heme, through its ability both to release iron for use in the generation of the hydroxyl radical and to induce the stress protein HO-1, has a pivotal role in the balance between cellular damage and protection during the breakdown of heme proteins in muscle ischemia. The regulation of heme turnover is critical to this; therefore, the heme oxygenase proteins, especially HO-1, can be expected to contribute significantly to cellular protection.
![]() |
ACKNOWLEDGEMENTS |
---|
We are grateful to Prof. S. Shibahara, Tohoku University School of Medicine, Sendai, Japan, for donating the cDNA probe for the rat HO-1 gene; to Dr. S. Mohammed, Royal Free Hospital Medical School, London, UK, for donating the cDNA probe for the rat GAPDH gene; and also to Dr. R. Martin, Blond McIndoe Centre, Queen Victoria Hospital, East Grinstead, Sussex, UK, for help in the preparation of the cDNA probe to the HO-1 gene.
![]() |
FOOTNOTES |
---|
This work was supported in part by Restoration of Appearance and Functional Trust Institute of Plastic Surgery.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: M. Vesely or R. Motterlini, Vascular Biology Unit, Dept. of Surgical Research, Y Block, NPIMR, Northwick Park Hospital, Watford Rd., Harrow, Middlesex HA1 3UJ, UK.
Received 17 February 1998; accepted in final form 8 July 1998.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Abraham, N. G.,
G. S. Drummond,
J. D. Lutton,
and
A. Kappas.
The biological significance and physiological role of heme oxygenase.
Cell. Physiol. Biochem.
6:
129-168,
1996.
2.
Chomczynski, P.,
and
N. Sacchi.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:
156-159,
1987[Medline].
3.
Durante, W.,
M. H. Kroll,
N. Christodoulides,
K. J. Peyton,
and
A. I. Schafer.
Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells.
Circ. Res.
80:
557-564,
1997
4.
Essig, D. A.,
D. R. Borger,
and
D. A. Jackson.
Induction of heme oxygenase-1 (HSP32) mRNA in skeletal muscle following contractions.
Am. J. Physiol.
272 (Cell Physiol. 41):
C59-C67,
1997
5.
Foresti, R.,
J. E. Clark,
C. J. Green,
and
R. Motterlini.
Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells. Involvement of superoxide and peroxynitrite anions.
J. Biol. Chem.
272:
18411-18417,
1997
6.
Furchgott, R. F.,
and
D. Jothianandan.
Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light.
Blood Vessels
28:
52-61,
1991[Medline].
7.
Gutteridge, J. M.
Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides.
FEBS Lett.
201:
291-295,
1986[Medline].
8.
Immenschuh, S.,
S. Iwahara,
H. Satoh,
C. Nell,
N. Katz,
and
U. Muller Eberhard.
Expression of the mRNA of heme-binding protein 23 is coordinated with that of heme oxygenase-1 by heme and heavy metals in primary rat hepatocytes and hepatoma cells.
Biochemistry
34:
13407-13411,
1995[Medline].
9.
Kim, T.-M.,
H. A. Bergonia,
C. Müller,
B. R. Pitt,
W. D. Watkins,
and
J. R. Lancaster, Jr.
Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis.
J. Biol. Chem.
270:
5710-5713,
1995
10.
Laemmli, U. K.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:
680-685,
1970[Medline].
11.
McCord, J. M.
Oxygen-derived free radicals in postischemic tissue injury.
N. Engl. J. Med.
312:
159-163,
1985[Abstract].
12.
McCoubrey, W. K., Jr.,
T. J. Huang,
and
M. D. Maines.
Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3.
Eur. J. Biochem.
247:
725-732,
1997[Abstract].
13.
Maines, M. D.
Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications.
FASEB J.
2:
2557-2568,
1988
14.
Maines, M. D.
The heme oxygenase system: a regulator of second messenger gases.
Annu. Rev. Pharmacol. Toxicol.
37:
517-554,
1997[Medline].
15.
Maines, M. D.,
R. D. Mayer,
J. F. Ewing,
and
W. K. McCoubrey, Jr.
Induction of kidney heme oxygenase-1 (HSP32) mRNA and protein by ischemia/reperfusion: possible role of heme as both promotor of tissue damage and regulator of HSP32.
J. Pharmacol. Exp. Ther.
264:
457-462,
1993[Abstract].
16.
Maines, M. D.,
G. M. Trakshel,
and
R. K. Kutty.
Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible.
J. Biol. Chem.
261:
411-419,
1986
17.
Motterlini, R.,
R. Foresti,
M. Intaglietta,
and
R. M. Winslow.
NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium.
Am. J. Physiol.
270 (Heart Circ. Physiol. 39):
H107-H114,
1996
18.
Motterlini, R.,
R. Foresti,
K. Vandegriff,
M. Intaglietta,
and
R. M. Winslow.
Oxidative-stress response in vascular endothelial cells exposed to acellular hemoglobin solutions.
Am. J. Physiol.
269 (Heart Circ. Physiol. 38):
H648-H655,
1995
19.
Murphy, B. J.,
K. R. Laderoute,
S. M. Short,
and
R. M. Sutherland.
The identification of heme oxygenase as a major hypoxic stress protein in Chinese hamster ovary cells.
Br. J. Cancer
64:
69-73,
1991[Medline].
20.
Nath, K. A.,
G. Balla,
G. M. Vercellotti,
J. Balla,
H. S. Jacob,
M. D. Levitt,
and
M. E. Rosenberg.
Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat.
J. Clin. Invest.
90:
267-270,
1992[Medline].
21.
Oddis, C. V.,
and
M. S. Finkel.
Cytokine-stimulated nitric oxide production inhibits mitochondrial activity in cardiac myocytes.
Biochem. Biophys. Res. Commun.
213:
1002-1009,
1995[Medline].
22.
Otterbein, L.,
S. L. Sylvester,
and
A. M. Choi.
Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1.
Am. J. Respir. Cell Mol. Biol.
13:
595-601,
1995[Abstract].
23.
Paller, M. S.
Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity.
Am. J. Physiol.
255 (Renal Fluid Electrolyte Physiol. 24):
F539-F544,
1988
24.
Prasad, M. R.,
R. M. Engelman,
R. M. Jones,
and
D. K. Das.
Effects of oxyradicals on oxymyoglobin. Deoxygenation, haem removal and iron release.
Biochem. J.
263:
731-736,
1989[Medline].
25.
Rajanayagam, M. A. S.,
C. G. Li,
and
M. J. Rand.
Differential effects of hydroxocobalamin on NO-mediated relaxations in rat aorta and anococcygeus muscle.
Br. J. Pharmacol.
108:
3-5,
1993[Medline].
26.
Ramakrishna Rao, D. N.,
and
A. I. Cederbaum.
Generation of reactive oxygen species by the redox cycling of nitroprusside.
Biochim. Biophys. Acta
1289:
195-202,
1996[Medline].
27.
Shah, S. V.,
and
P. D. Walker.
Evidence suggesting a role for hydroxyl radical in glycerol-induced acute renal failure.
Am. J. Physiol.
255 (Renal Fluid Electrolyte Physiol. 24):
F438-F443,
1988
28.
Shen, S.,
S. Sangiah,
and
M. Ye.
Determination of hydroxyl radical formation in the testes of cadmium-treated mice by high-performance liquid-chromatography.
J. Liq. Chromatogr.
18:
2217-2228,
1995.
29.
Shibahara, S.,
R. M. Muller,
and
H. Taguchi.
Transcriptional control of rat heme oxygenase by heat shock.
J. Biol. Chem.
262:
12889-12892,
1987
30.
Shibahara, S.,
R. Muller,
H. Taguchi,
and
T. Yoshida.
Cloning and expression of cDNA for rat heme oxygenase.
Proc. Natl. Acad. Sci. USA
82:
7865-7869,
1985[Abstract].
31.
Shibahara, S.,
T. Yoshida,
and
G. Kikuchi.
Induction of heme oxygenase by hemin in cultured pig alveolar macrophages.
Arch. Biochem. Biophys.
188:
243-250,
1978[Medline].
32.
Stocker, R.,
Y. Yamamoto,
A. F. McDonagh,
A. N. Glazer,
and
B. N. Ames.
Bilirubin is an antioxidant of possible physiological importance.
Science
235:
1043-1046,
1987[Medline].
33.
Tenhunen, R.,
H. S. Marver,
and
R. Schmid.
The enzymatic catabolism of hemoglobin: stimulation of microsomal heme oxygenase by hemin.
J. Lab. Clin. Med.
75:
410-421,
1970[Medline].
34.
Trakshel, G. M.,
R. K. Kutty,
and
M. D. Maines.
Cadmium-mediated inhibition of testicular heme oxygenase activity: the role of NADPH-cytochrome c (P-450) reductase.
Arch. Biochem. Biophys.
251:
175-187,
1986[Medline].
35.
Tyrrell, R. M.,
and
S. Basu Modak.
Transient enhancement of heme oxygenase 1 mRNA accumulation: a marker of oxidative stress to eukaryotic cells.
Methods Enzymol.
234:
224-235,
1994[Medline].
36.
Vogt, B. A.,
J. Alam,
A. J. Croatt,
G. M. Vercellotti,
and
K. A. Nath.
Acquired resistance to acute oxidative stress. Possible role of heme oxygenase and ferritin.
Lab. Invest.
72:
474-483,
1995[Medline].
37.
Yoshida, T.,
P. Biro,
T. Cohen,
R. M. Muller,
and
S. Shibahara.
Human heme oxygenase cDNA and induction of its mRNA by hemin.
Eur. J. Biochem.
171:
457-461,
1988[Abstract].